Li Si, Xu Fangying, Zhang Jing, Wang Lili, Zheng Yang, Wu Xuesong, Wang Jing, Huang Qiong, Lai Maode
Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Oncoimmunology. 2017 Oct 11;7(2):e1380765. doi: 10.1080/2162402X.2017.1380765. eCollection 2018.
The immune contexture, a composition of the tumor microenvironment, plays multiple important roles in cancer stem cell (CSC) and epithelial-mesenchymal transition (EMT), and hence critically influences tumor initiation, progression and patient outcome. Tumor-associated macrophages (TAMs) are abundant in immune contexture, however their roles in CSC, EMT and prognosis of colorectal cancer (CRC) have not been elucidated. In 419 colorectal carcinomas, immune cell types (CD68 macrophages, CD3, CD4 or CD8 T lymphocytes, CD20 B lymphocytes), EMT markers (E-cadherin and Snail) as well as the stem cell marker (CD44v6) were detected in tumor center (TC) and tumor invasive front (TF) respectively by immunohistochemistry. Tumor buds, that represent EMT phenotype, were also counted. It was found CD68 macrophages were the most infiltrating immune cells in CRC. By correlation analysis, more CD68 macrophages were associated with more CD44v6 expression (p < 0.001), lower Snail expression (p = 0.08) and fewer tumor buds (p < 0.001). More CD68 macrophages were significantly related to more CD3 T lymphocytes (p = 0.002), CD8 T lymphocytes (p < 0.001) and CD20 B lymphocytes counts (p = 0.004). Strong CD68 macrophages infiltration also predicted long term overall survival. CRC patients with more tumor buds had worse survival. However, strong CD68 macrophages infiltration could reverse the unfavorable results since patients with more tumor buds but increasing CD68 macrophages infiltration had the favorable outcome, similar to lower tumor buds groups. This study provided direct morphological evidence that tumor-associated macrophages in the invasive front play critical roles in fighting with the unfavorable results of tumor buds, thus resulting favorable outcomes for CRC patients.
免疫微环境作为肿瘤微环境的组成部分,在癌症干细胞(CSC)和上皮-间质转化(EMT)中发挥多种重要作用,因此对肿瘤的发生、发展及患者预后有着至关重要的影响。肿瘤相关巨噬细胞(TAM)在免疫微环境中大量存在,但其在CSC、EMT及结直肠癌(CRC)预后中的作用尚未阐明。在419例结直肠癌中,通过免疫组织化学分别检测肿瘤中心(TC)和肿瘤浸润前沿(TF)的免疫细胞类型(CD68巨噬细胞、CD3、CD4或CD8 T淋巴细胞、CD20 B淋巴细胞)、EMT标志物(E-钙黏蛋白和Snail)以及干细胞标志物(CD44v6)。还对代表EMT表型的肿瘤芽进行了计数。结果发现,CD68巨噬细胞是CRC中浸润最多的免疫细胞。通过相关性分析,更多的CD68巨噬细胞与更多的CD44v6表达相关(p<0.001)、较低的Snail表达(p = 0.08)和较少的肿瘤芽(p<0.001)。更多的CD68巨噬细胞与更多的CD3 T淋巴细胞(p = 0.002)、CD8 T淋巴细胞(p<0.001)和CD20 B淋巴细胞计数显著相关(p = 0.004)。CD68巨噬细胞的强烈浸润也预示着长期总生存期。肿瘤芽较多的CRC患者生存率较差。然而,CD68巨噬细胞的强烈浸润可以扭转不利结果,因为肿瘤芽较多但CD68巨噬细胞浸润增加的患者有良好的预后,类似于肿瘤芽较少的组。本研究提供了直接的形态学证据,表明浸润前沿的肿瘤相关巨噬细胞在对抗肿瘤芽的不利结果中起关键作用,从而为CRC患者带来良好的预后。